Leung, Wing Hang
Duke-NUS Medical School,
Singapore
2025 Rank: 133403
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2397 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 133403 | 134182 |
| Total Cites | 732 | 823 |
| H-index | 13 | 14 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 54 | 56 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 186 | 199 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 607 | 677 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.22 |
| Self-Citation Percentage |
11.06%
|
|
Leung, Wing Hang
The University of Hong Kong,
Hong Kong
2024 Rank: 131153
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2468 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 131153 | 133567 |
| Total Cites | 686 | 787 |
| H-index | 11 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 34 | 34 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 173 | 182 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 589 | 660 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
12.83%
|
|
Leung, Wing Hang
The University of Hong Kong,
Hong Kong
2023 Rank: 74190
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1643 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74190 | 76183 |
| Total Cites | 731 | 823 |
| H-index | 13 | 14 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 15 | 16 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 70 | 74 |
| Number of Single+First+Last Authored Papers | 75 | 75 |
| Total Cites to Single+First+Last Authored Papers | 216 | 227 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 575 | 630 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.31 |
| Self-Citation Percentage |
11.18%
|
|
Leung, Wing Hang
The University of Hong Kong,
Hong Kong
2022 Rank: 46233
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1167 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 46233 | 55653 |
| Total Cites | 834 | 918 |
| H-index | 14 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 19 | 19 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 81 | 82 |
| Number of Single+First+Last Authored Papers | 74 | 74 |
| Total Cites to Single+First+Last Authored Papers | 293 | 297 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 640 | 696 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.32 |
| Self-Citation Percentage |
9.15%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.